Hopkins Team Shows New Ways To Prevent Brain Damage During Cardiac Surgery

November 08, 1997

An unlikely team of heart surgeons and brain chemistry experts at Johns Hopkins has experimental evidence that some common drugs including anti-seizure medications may reduce or eliminate the most feared risk to people facing heart bypass surgery -- inevitable, if often subtle, brain damage.

Five years into an eight-year National Institutes of Health grant, the Hopkins team has conducted laboratory tests with chemicals that dramatically protect animal brains from the kind of damage that occurs during heart surgery. Patient trials are expected to start in early 1998.

"The truth is that surgeons have gone about as far as they can go to indirectly protect the brain from injury by both decreasing operating time and refining cardiopulmonary bypass (the heart-lung machine)," says William A. Baumgartner, M.D., chief of cardiac surgery. "Since satisfactory methods have been developed to protect the heart during open-heart operations, the next challenge is to protect the brain.

"Our goal has been two-fold. We want to define the cellular and biochemical mechanism of nerve cell injury and then develop pharmacologic strategies to reduce the injury."

Baumgartner likened the neuroprotective strategy to newer tactics in the battle to reduce death and injuries from auto accidents. "The first approach years ago was driver education -- getting people to avoid accidents and reduce their frequency. But accidents persisted, so the next phase was to build a more protective car, with better brakes, air bags and seat belts. If you know that every time people get behind the wheel some accidents are inevitable, then the goal becomes making those accidents less harmful, regardless of the cause."

The apparently protective drugs tested at Hopkins inhibit overproduction of the neurotransmitter glutamate (an excitatory amino acid), glutamate receptors like N-methyl-D-aspartase, and nitric oxide. The team has shown in several published studies that, when administered, these medications result in far less brain cell damage and document better neurologic outcomes after undergoing bypass surgery.

In a paper to be presented 8 a.m., Nov. 8 at the Southern Thoracic Surgical Association annual meeting in Naples, Fla., the researchers report that 17477AR, an inhibitor of the enzyme nitric oxide synthase, significantly reduced brain cell death in a model of open-heart surgery, where brain damage is known to occur. The particular areas of the brain affected are those that involve memory and learning.

One of the documented causes of brain damage has been an excessive accumulation of glutamate, the major neurotransmitter in the brain. This can cause over activation of brain nerve cell receptors, triggering a cascade of cellular events that lead ultimately to cell death. Nitric oxide, a chemical normally involved in many body functions, also has been implicated as a mediator of glutamate neurotoxicity. The medications being tested aim to interrupt this cascade and preserve cognitive function.

In the current study, researchers measured brain levels of nitric oxide, comparing the drug 17477AR with controls. They found that the medication reduced production of citrulline (a marker of nitric oxide) by 58 percent. Superior neurologic function also was demonstrated compared with controls.

"These results provide the first evidence that nitric oxide mediates brain cell death in a model of open-heart surgery and that nitric oxide synthase plays a significant role in this neurotoxicity," says Elaine E. Tseng, M.D., lead author of the study and a cardiac surgery fellow. "Pharmacologic strategies to inhibit nitric oxide synthase may be clinically beneficial."

The study was supported by the National Institutes of Health and the Nina Braunwald Research Fellowship from the Thoracic Surgery Foundation for Research and Education. The co-authors were Malcolm V. Brock, M.D.; Mary S. Lange, M.A.; Jorge D. Salazar, M.D.; John R. Doty, M.D.; Charles J. Lowenstein, M.D.; Juan C. Troncoso, M.D.; Mary E. Blue, Ph.D.; Michael V. Johnston, M.D.; and Baumgartner.

For the more than 400,000 Americans a year undergoing coronary artery bypass surgery, refined surgical techniques have improved outcomes almost to the limits of "driver ed," with mortality overall at less than 3 percent at the best medical centers, even among a rapidly aging patient population. At Hopkins, for example, in 1996, the mortality rate was just 2.8 percent overall, despite a patient population that has aged rapidly. Thirty-five percent of patients that year were more than 70 years old.

With the increasing age of patients undergoing cardiac surgery, cerebral complications represent one of the leading causes of morbidity and mortality in this group of patients. Neurological disturbances also are associated with increased length of stay and costs.

--JHMI--

Media contact: Karen Infeld(410)955-1534
E-mail: kinfeld@welchlink.welch.jhu.edu




Johns Hopkins Medical Institutions' news releases are available on a PRE-EMBARGOED basis on EurekAlert at http://www.eurekalert.org, Newswise at http://www.newswise.com and from the Office of Communications and Public Affairs' direct e-mail news release service. To enroll, call 410-955-4288 or send e-mail to bsimpkin@welchlink.welch.jhu.edu or 76520.560@compuserve.com.

On a POST-EMBARGOED basis find them at http://hopkins.med.jhu.edu, Quadnet at http://www.quad-net.com, ScienceDaily at http://www.sciencedaily.com or on CompuServe in the SciNews-MedNews library of the Journalism Forum under file extension ".JHM".



Johns Hopkins Medicine

Related Brain Articles from Brightsurf:

Glioblastoma nanomedicine crosses into brain in mice, eradicates recurring brain cancer
A new synthetic protein nanoparticle capable of slipping past the nearly impermeable blood-brain barrier in mice could deliver cancer-killing drugs directly to malignant brain tumors, new research from the University of Michigan shows.

Children with asymptomatic brain bleeds as newborns show normal brain development at age 2
A study by UNC researchers finds that neurodevelopmental scores and gray matter volumes at age two years did not differ between children who had MRI-confirmed asymptomatic subdural hemorrhages when they were neonates, compared to children with no history of subdural hemorrhage.

New model of human brain 'conversations' could inform research on brain disease, cognition
A team of Indiana University neuroscientists has built a new model of human brain networks that sheds light on how the brain functions.

Human brain size gene triggers bigger brain in monkeys
Dresden and Japanese researchers show that a human-specific gene causes a larger neocortex in the common marmoset, a non-human primate.

Unique insight into development of the human brain: Model of the early embryonic brain
Stem cell researchers from the University of Copenhagen have designed a model of an early embryonic brain.

An optical brain-to-brain interface supports information exchange for locomotion control
Chinese researchers established an optical BtBI that supports rapid information transmission for precise locomotion control, thus providing a proof-of-principle demonstration of fast BtBI for real-time behavioral control.

Transplanting human nerve cells into a mouse brain reveals how they wire into brain circuits
A team of researchers led by Pierre Vanderhaeghen and Vincent Bonin (VIB-KU Leuven, Université libre de Bruxelles and NERF) showed how human nerve cells can develop at their own pace, and form highly precise connections with the surrounding mouse brain cells.

Brain scans reveal how the human brain compensates when one hemisphere is removed
Researchers studying six adults who had one of their brain hemispheres removed during childhood to reduce epileptic seizures found that the remaining half of the brain formed unusually strong connections between different functional brain networks, which potentially help the body to function as if the brain were intact.

Alcohol byproduct contributes to brain chemistry changes in specific brain regions
Study of mouse models provides clear implications for new targets to treat alcohol use disorder and fetal alcohol syndrome.

Scientists predict the areas of the brain to stimulate transitions between different brain states
Using a computer model of the brain, Gustavo Deco, director of the Center for Brain and Cognition, and Josephine Cruzat, a member of his team, together with a group of international collaborators, have developed an innovative method published in Proceedings of the National Academy of Sciences on Sept.

Read More: Brain News and Brain Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.